Global Careers Investors Fagron worldwide Register Login Home Vision Mission & Strategy Optimize and innovate personalized pharmaceutical care. Fagron Values Our values define what we are and what we aim to be. Pharmaceutical compounding Pharmaceutical compounding, personalized pharmaceutical products. Cases Bringing innovative solutions. Fagron Advanced Derma Leading advanced dermatological care. Code of Conduct & Ethics Doing business as a global pharmaceutical company. Knowledge Knowledge Search Search form Compounding MSDS CoA Search Our Innovative Concepts Innovative concepts and solutions for all challenges in compounding pharmacies. View our innovative concepts Compounding Matters Fagron's database of compounding formulations. Documents (MSDS & CoA) Documents (MSDS & CoA). Terminology List Terminology List. R&D Research & Development Matching the most optimal personalized medication with the patient’s needs is the essence of compounding. Pipeline Personalized pharmaceutical solutions and concepts that significantly improve patients' lives. Dermatology Fagron Advanced Derma is the global standard for advanced individual dermatological care. Pain Our R&D department focuses on a concept aimed at pain management which will be introduced in 2019. Oral Suspending Vehicles With SyrSpend® SF, Fagron enables pharmacists to efficiently prepare stable oral liquid dosage forms. Quality Quality Management More than 200,000 customers have access to over 2,500 high-quality pharmaceutical raw materials. Quality Activities Quality tasks in coordination with procurement, sales, production and in general. Supplier qualifications and audits Qualification of a product is a cooperation between Fagron Procurement and Fagron Quality. Falsified Medicines Directive The Falsified Medicines EU Directive 2011/62/EU is in force from 2 July 2013. Documentation and Records Documents (CoA, MSDS and technical specifications) are available for all our products. Company Fagron Academy Training courses and lectures to enhance compounding skills and knowledge. Fagron Foundation Fagron contributes to improve the welfare of children. Careers Explore Fagron's career opportunities. Fagron Leadership team Introduction members of Fagron Leadership team. News Latest news items and news archive. Fagron History From local player to global market leader in pharmaceutical compounding. Press Enter your keywords Search in Website Search in MSDS Search in CoA Case study Isabella has alopecia areata Isabella's case The challenge The case Isabella, a 35 year old female volleyball player, suffers from alopecia areata. As a result she recently started loosing her eyelashes and eyebrows. The eyelashes and eyebrows have a protective as well as an aesthetic function. Additionally, they also establish personal identity. During her competitive volleyball matches the sweat drips into her eyes which has a stinging effect. The challenge The solution The challenge Her physician prescribes latanoprost to regrow the eyelashes and eyebrows and to help regain her self-esteem. A skin-friendly and compatible vehicle is needed with a viscosity that allows easy application preventing from running into the eyes. Moreover, application on this delicate specific skin area can be challenging and needs to be done with the right tools. The solution The Cure The solution Seraqua™ is an ultra-light and readily vanishing serum. It is an ideal compounding vehicle for a broad range of APIs, including latanoprost. Seraqua™ is highly suitable for application on the eyebrows and eyelids. It can be used in combination with Fagron’s pharmaceutical eyelid applicator to maximize ease of application and patient comfort. The cure Cases overview The cure Isabella received a prescription for latanoprost 0.005% in Seraqua™ from her physician. With Fagron’s latanoprost the pharmacist efficiently compounded the latanoprost 0.005% in 10 ml Seraqua™. After two months treatment the first results are very promising, expecting full regrowth of the eyelashes and eyebrows. Case study Laura has been struggling with the symptoms of mild psoriasis Laura's case The challenge The case Laura has been struggling with the symptoms of mild psoriasis for the past few years. She recently had an interview for a position as a flight attendant - her dream job. She visits her dermatologist to inquire about treating her symptoms with a more comfortable preparation than the one she already uses. The challenge The solution The challenge Psoriasis is often treated with traditional ointments, which can be very greasy and highly uncomfortable. Especially considering the fact that Laura will have to wear a uniform for stretches of time. The solution The Cure The solution Laura’s dermatologist has positive experiences with combinations of topical corticosteroids and emollients. Considering the dryness of the affected skin, he suggests an innovative ointment-based preparation. To guarantee Laura maximum comfort and results during therapy, he proposes Occluvan™, a Fagron Advanced Derma vehicle. The cure Cases overview The cure The dermatologist asks Laura’s pharmacist to compound clobetasol proprionate 0.05% and dexpanthenol 3% in Occluvan™, an innovative ointment base with minimal tackiness. Laura is very satisfied with the preparation’s elegance and comfortable skin feel. She now has her symptoms under control and recently received the news that she has been hired as a flight attendant. Case study Miquel has high blood pressure Miquel's case The challenge The Case Miguel (age three) has a genuine sweet tooth. She happily eats any treat her mother gives her. Last time they visited their family doctor, Miguel’s blood pressure was up in the 95th percentile for girls of her age. Today, the doctor checks her blood pressure again and diagnoses hypertension. He also tests for diabetes and wants to start Miguel on a dose of atenolol at 0.5 mg/kg/day. The challenge The solution The Challenge Miguel weighs 17 kg, so his doctor wants to prescribe him 8.5 mg atenolol per day. As this dosage is commercially unavailable, he calls the pharmacist to discuss compounding an oral suspension. Although he is concerned about giving young Miguel a suspension with preservatives and a high sugar content, he is not sure whether Miguel will accept his medication without taste masking. The solution The Cure The Solution The pharmacist has the perfect solution for Miguel’s situation. He suggests compounding a 1 mg/ml atenolol suspension with the Atenolol & SyrSpend® SF PH4 kit. SyrSpend® SF PH4 is sugar and preservative-free and has excellent taste-masking properties as well as a sweet, neutral taste. Beginning with a 1 mg/ml suspension, the dose can be adjusted over time as Miguel develops. The cure Cases overview The Cure Six months later, Miguel’s blood pressure has improved and his doctor wants to try to start lowering the dose of atenolol. The pre-diabetes signs that were initially present have diminished and almost gone. His mother has also cut back on the treats, and Miguel has become a lively young fellow. The doctor hopes to eventually have Miguel come off the medication completely. Case study Josh has problems swallowing Josh's case The challenge The Case Josh (35years old) is recovering from a Laryngeal cancer treatment. He’s doing well but he’s having problems swallowing solid food and medication. His wife is currently suffering a bad flue. Since Josh’s immune system is considered to be acquired after his cancer treatment his oncologist wants to prescribe Josh an oseltamivir treatment to prevent him from developing influenza as well. The challenge 1 2 3 4 next The Challenge Patient accessibility: Because Josh is having problems swallowing he needs a liquid dosage form, which is not available as a licensed product in the right dosage strength for Josh. 1 2 3 4 next The Challenge Patient acceptance: Josh is experiencing retching when feeling an unpleasant bitter taste in his mouth. Oseltamivir has a bitter taste. 1 2 3 4 next The Challenge Unpleasant side effects: Josh is suffering diarrhea and other gastrointestinal discomfort due to his cancer medication. Stomach distress and diarrhoea are seen with sorbitol containing suspending vehicles. 1 2 3 4 The Challenge Proven stability: The stability of oseltamivir in a fluid form needs special attention. The solution 1 2 3 4 5 next The Solution With the focus on patient, prescriber and pharmacist, Fagron offers unique solutions that add significant value in the individualized treatment of patients with specific needs. Also for Josh. 1 2 3 4 5 next The Solution Patient accessibility: With SyrSpend® SF PH4 pharmacists can easily compound a 15 mg/ml oseltamivir suspension, based on oseltamivir capsules. Wich can be used with a broad variety of active pharmaceutical ingredients (APIs). 1 2 3 4 5 next The Solution Patient acceptance: SyrSpend® SF PH4 is available in cherry flavour and unflavored, both with taste-masking capacities to cover the bitter taste of oseltamivir. Flavoring concentrates from the SyrSpend® SF Flavoring Kit may be added to the neutral versions to customize to Josh’s individual preference. 1 2 3 4 5 next The Solution Unpleasant side effects: Low osmolality of SyrSpend® SF PH4 minimizes the risk of stomach distress and diarrhea. Preparation is free from alcohol, parabens, sorbitol, sugars, gluten and colorants and is also available as a preservative-free powder for reconstitution. 1 2 3 4 5 The Solution Proven stability: Stability tests have proven a 30 days stability of a suspension of SyrSpend® SF PH4 with oseltamivir*. The cure 1 2 next The Cure A simple process of mixing the oseltamivir capsule contents with SyrSpend® SF PH4 enables the pharmacist to prepare a stable suspension in just minutes for Josh. 1 2 The Cure Josh his energy level is improving and he’s eating more and more solid food again. Last week he and his wife booked a holiday out of their dreams to Hawaii and he’s looking forward to it. Josh is enjoying life. Laura has been struggling with the symptoms of mild psoriasis Pages 1 2 3 4 Together we create the future of personalized medicine. Our ability to listen to our customers and to work closely together with pharmacists, prescribers and universities worldwide is the foundation of our successful strategy of optimizing and innovating personalized pharmaceutical care. Learn more about compounding News: Visit us at IMCAS 2020 Fagron Genomics is participating in the IMCAS World Congress, the biggest medical conference bringing together international experts in plastic surgery, dermatology and aesthetic science. Read this article Fagron Concepts Fagron Advanced Derma Leading advanced dermatological care Read more SyrSpend® SF Oral liquid vehicles Read more Nourisil™ MD Advanced scar treatment Read more View all Fagron Concepts No front page content has been created yet. Videos Pentravan Lollibase Espumil Versatile Accu-Tenth "Fagron Foundation" The goal is to leverage human and financial resources to drive social change and healthcare and community improvements. The main focus is on improving the welfare of children. Read more about Fagron Foundation Read more Fagron Channels Fagron Compounding Matters Patient care started with compounding. Compounding still matters. Read more Fagron Partner Program The local partner programs shows our appreciation to our loyal customers. Read more Fagron Academy Fagron provides training courses to pharmacists to further enhance their skills in the pharmaceutical compounding of customized medication. Read more Fagron Foundation The goal is to leverage human and financial resources to drive social change and healthcare and community improvements. Read more Fagron TV Fagron TV is a channel developed by Fagron to provide more knowledge about compounding. Read more Learn more about careers at Fagron View jobs Let's keep in touch. Contact us Privacy Statement Disclaimer © Copyright 2012-2019 Fagron. All rights reserved.